| Name | Lademirsen |
|---|
| Description | Lademirsen (SAR339375; RG-012) is a highly specific antisense oligonucleotide (ASO) targeting miR-21. Lademirsen has the potential for Alport nephropathy research[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Administration of Lademirsen (SAR339375; RG-012) to inhibit miR-21 leads to a slowed progression of renal fibrosis and an increased lifespan in Alport syndrome mouse models[1]. |
| References |
| No Any Chemical & Physical Properties |